Water soluble fluorescent or colored dyes and methods for their use
US-9689877-B2 · Jun 27, 2017 · US
US12461106B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12461106-B2 |
| Application number | US-202418436594-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 8, 2024 |
| Priority date | Apr 6, 2016 |
| Publication date | Nov 4, 2025 |
| Grant date | Nov 4, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I):or a stereoisomer, tautomer or salt thereof, wherein R1, R2, R3, R4, R5, L1, L2, L3, L4, M, m and n are as defined herein. Methods associated with preparation and use of such compounds are also provided.
Opening claim text (preview).
What is claimed is: 1 . A compound having the following structure (IA): or a stereoisomer, salt or tautomer thereof, wherein: M is, at each occurrence, independently a fluorescent dye, wherein at least one occurrence of M has absorbance for use in fluorescence resonance energy transfer (FRET), and at least one occurrence of M has emissions for use in FRET; L 1 is at each occurrence, independently either i) an alkylene linker; ii) a heteroalkylene linker including at least one nitrogen atom; or iii) a linker comprising a triazolyl functional group; L 2 and L 3 are, at each occurrence, independently an alkylene or heteroalkylene linker; R 1 is, at each occurrence, H; R 2 is Q, or a protected form thereof, or a linker comprising a covalent bond to Q; R 3 comprises a deoxythymidine (dT) group; R 4 is, at each occurrence, OH, O − or OR d ; R 5 is, at each occurrence, oxo; R d is a counter ion; Q is a moiety comprising a sulfhydryl, disulfide, activated ester, isothiocyanate, azide, alkyne, alkene, diene, dienophile, acid halide, sulfonyl halide, phosphine, «-haloamide, biotin, amino or maleimide functional group, wherein the activated ester is an N-succinimide ester, imidoester or polyflourophenyl ester, and wherein the azide is an alkyl azide or acyl azide; m is, at each occurrence, independently an integer of one to 10; n is an integer of one to 32; and z is an integer from 2 to 25. 2 . The compound of claim 1 , wherein for at least one occurrence of L 1 , L 1 -M has the following structure: wherein L 1a and L 1b are each independently optional linkers. 3 . The compound of claim 1 , wherein for at least one occurrence of L 1 , L 1 -M has the following structure: wherein L 1a and L 1b are each independently optional linkers. 4 . The compound of claim 2 , wherein L 1a or L 1b , or both, is absent. 5 . The compound of claim 2 , wherein L 1a or L 1b , or both, is present. 6 . The compound of claim 5 , wherein L 1a and L 1b , when present, are each independently alkylene or heteroalkylene. 7 . The compound of claim 5 , wherein L 1a and L 1b , when present, independently have one of the following structures: 8 . The compound of claim 1 , wherein R 4 is, at each occurrence, O − . 9 . The compound of claim 1 , wherein Q is capable of forming a covalent bond with a targeting moiety that is an antibody or cell surface receptor antagonist. 10 . The compound of claim 1 , wherein L 2 and L 3 are, at each occurrence, a methylene linker. 11 . The compound of claim 1 , wherein R 2 has the following structure: 12 . The compound of claim 1 , wherein L 2 -R 3 comprises the following structure: 13 . The compound of claim 1 , wherein Q is a moiety selected from 14 . The compound of claim 1 , wherein Q is capable of forming a covalent bond with an analyte molecule that is a nucleic acid, amino acid or a polymer thereof, an enzyme, receptor, receptor ligand, antibody, glycoprotein, aptamer or prion. 15 . The compound of claim 1 , wherein one M is a FRET acceptor. 16 . The compound of claim 1 , wherein z is an integer from 2 to 10. 17 . The compound of claim 1 , wherein z is an integer from 3 to 6. 18 . The compound of claim 1 , wherein R 2 comprises alkylene oxide. 19 . The compound of claim 1 , wherein R 3 comprises alkylene oxide.
containing other specific dyes · CPC title
containing a perylene dye · CPC title
containing an anthracene dye · CPC title
Triarylmethane dyes in which at least one of the aromatic nuclei is heterocyclic {(phthaleins C09B11/24)} · CPC title
Perylene derivatives · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.